Literature DB >> 25986245

Recognizing the Financial Burden of Cancer Patients in Clinical Trials.

Ryan D Nipp1, Elizabeth Powell2, Bruce Chabner2, Beverly Moy2.   

Abstract

Entities:  

Keywords:  Clinical trial; Cost of illness; Financial support; Health care costs; Quality of life

Mesh：

Year:  2015        PMID： 25986245      PMCID： PMC4571792          DOI： 10.1634/theoncologist.2015-0068

Source DB:  PubMed          Journal:  Oncologist        ISSN： 1083-7159


× No keyword cloud information.
  27 in total

1.  The costs of conducting clinical research.

Authors:  Ezekiel J Emanuel; Lowell E Schnipper; Deborah Y Kamin; Jenifer Levinson; Allen S Lichter
Journal:  J Clin Oncol       Date:  2003-10-14       Impact factor: 44.544

2.  Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment.

Authors:  P N Lara; R Higdon; N Lim; K Kwan; M Tanaka; D H Lau; T Wun; J Welborn; F J Meyers; S Christensen; R O'Donnell; C Richman; S A Scudder; J Tuscano; D R Gandara; K S Lam
Journal:  J Clin Oncol       Date:  2001-03-15       Impact factor: 44.544

3.  Measuring the incremental cost of clinical cancer research.

Authors:  D P Goldman; M L Schoenbaum; A L Potosky; J C Weeks; S H Berry; J J Escarce; B A Weidmer; M L Kilgore; N Wagle; J L Adams; R A Figlin; J H Lewis; J Cohen; R Kaplan; M McCabe
Journal:  J Clin Oncol       Date:  2001-01-01       Impact factor: 44.544

4.  How sociodemographics, presence of oncology specialists, and hospital cancer programs affect accrual to cancer treatment trials.

Authors:  Warren B Sateren; Edward L Trimble; Jeffrey Abrams; Otis Brawley; Nancy Breen; Leslie Ford; Mary McCabe; Richard Kaplan; Malcolm Smith; Richard Ungerleider; Michaele C Christian
Journal:  J Clin Oncol       Date:  2002-04-15       Impact factor: 44.544

5.  The impact of serious illness on patients' families. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatment.

Authors:  K E Covinsky; L Goldman; E F Cook; R Oye; N Desbiens; D Reding; W Fulkerson; A F Connors; J Lynn; R S Phillips
Journal:  JAMA       Date:  1994-12-21       Impact factor: 56.272

6.  The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology.

Authors:  N K Aaronson; S Ahmedzai; B Bergman; M Bullinger; A Cull; N J Duez; A Filiberti; H Flechtner; S B Fleishman; J C de Haes
Journal:  J Natl Cancer Inst       Date:  1993-03-03       Impact factor: 13.506

7.  Participation in cancer clinical trials: race-, sex-, and age-based disparities.

Authors:  Vivek H Murthy; Harlan M Krumholz; Cary P Gross
Journal:  JAMA       Date:  2004-06-09       Impact factor: 56.272

8.  A validation study of the domains of the core EORTC quality of life questionnaire.

Authors:  H E Niezgoda; J L Pater
Journal:  Qual Life Res       Date:  1993-10       Impact factor: 4.147

9.  Incremental treatment costs in national cancer institute-sponsored clinical trials.

Authors:  Dana P Goldman; Sandra H Berry; Mary S McCabe; Meredith L Kilgore; Arnold L Potosky; Michael L Schoenbaum; Matthias Schonlau; Jane C Weeks; Richard Kaplan; Jose J Escarce
Journal:  JAMA       Date:  2003-06-11       Impact factor: 56.272

10.  Enrollment of elderly patients in clinical trials for cancer drug registration: a 7-year experience by the US Food and Drug Administration.

Authors:  Lilia Talarico; Gang Chen; Richard Pazdur
Journal:  J Clin Oncol       Date:  2004-11-15       Impact factor: 44.544
View more
  20 in total

1.  Science in the Heartland: Exploring determinants of offering cancer clinical trials in rural-serving community urology practices.

Authors:  Shellie D Ellis; Mugur Geana; Christine B Mackay; Deborah J Moon; Jessie Gills; Andrew Zganjar; Gayle Brekke; J Brantley Thrasher; Tomas L Griebling
Journal:  Urol Oncol       Date:  2019-03-29       Impact factor: 3.498

2.  At What Cost to Clinical Trial Enrollment? A Retrospective Study of Patient Travel Burden in Cancer Clinical Trials.

Authors:  Hala T Borno; Li Zhang; Adam Siegel; Emily Chang; Charles J Ryan
Journal:  Oncologist       Date:  2018-04-26

3.  Influence of travel burden on tumor classification and survival of head and neck cancer patients.

Authors:  J M Vahl; A von Witzleben; C Welke; J Doescher; M N Theodoraki; M Brand; P J Schuler; J Greve; T K Hoffmann; S Laban
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-04-20       Impact factor: 2.503

4.  Clinical Trials, Disparities, and Financial Burden: It's Time to Intervene.

Authors:  Beverly Moy
Journal:  Oncologist       Date:  2015-05-18

Review 5.  Implementing Digital Technologies in Clinical Trials: Lessons Learned.

Authors:  Georgia Mitsi; Todd Grinnell; Suzanne Giordano; Thomas Goodin; Shahin Sanjar; Elizabeth Marble; Andrei Pikalov
Journal:  Innov Clin Neurosci       Date:  2022 Apr-Jun

6.  Factors associated with enrolment in clinical trials among women with early-stage breast cancer.

Authors:  D Presti; J Havas; D Soldato; P Lapidari; E Martin; B Pistilli; C Jouannaud; G Emile; O Rigal; M Fournier; P Soulie; M-A Mouret-Reynier; C Tarpin; M Campone; S Guillermet; A-L Martin; S Everhard; A Di Meglio
Journal:  ESMO Open       Date:  2022-06-17

7.  Understanding factors contributing to participant satisfaction in stroke walking recovery clinical trials.

Authors:  Mark Cummings; Sonia Pradhan; Sangeetha Madhavan
Journal:  Contemp Clin Trials Commun       Date:  2022-06-11

8.  Association of Remote Technology Use and Other Decentralization Tools With Patient Likelihood to Enroll in Cancer Clinical Trials.

Authors:  Devon V Adams; Sarah Long; Mark E Fleury
Journal:  JAMA Netw Open       Date:  2022-07-01

9.  Financial Burden of Cancer Clinical Trial Participation and the Impact of a Cancer Care Equity Program.

Authors:  Ryan D Nipp; Hang Lee; Elizabeth Powell; Nicole E Birrer; Emily Poles; Daniel Finkelstein; Karen Winkfield; Sanja Percac-Lima; Bruce Chabner; Beverly Moy
Journal:  Oncologist       Date:  2016-03-14

Review 10.  Overcoming Barriers to Parkinson Disease Trial Participation: Increasing Diversity and Novel Designs for Recruitment and Retention.

Authors:  Pavan A Vaswani; Thomas F Tropea; Nabila Dahodwala
Journal:  Neurotherapeutics       Date:  2020-11-04       Impact factor: 6.088
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.